Skip to main content

Advertisement

Log in

Adrenal function in relation to cytokines and outcome in non-critically ill patients with COVID-19

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

We aimed to identify whether hypothalamic–pituitary–adrenal (HPA) axis dysfunction is related to deterioration in a percentage of patients who progress to severe COVID-19.

Methods

In this cohort observational study, we evaluated HPA axis activation by measuring cortisol, adrenocorticotropic hormone (ACTH), dehydroepiandrosterone sulfate (DHEA-S) levels, whole blood expression levels of the key glucocorticoid receptor, GCR-α, and the glucocorticoid-induced leucine zipper (GILZ), and cytokines, as markers of the inflammatory phase, in 149 patients with respiratory infection admitted in the ward, without known adrenal disease and/or confounding medications (glucocorticoids). One hundred and four (104) patients were SARS-CoV-2 positive (C +) and controls consisted of 45 SARS-CoV-2-negative patients (NC).

Results

No differences in cortisol levels were observed between the C + and the NC patients. Cortisol levels correlated with ACTH (r = 0.284, p = 0.001) and IL-6 (r = 0.289, p = 0.04). In C + patients, cortisol levels mainly correlated with IL-6 levels (r = 0.28; p = 0.017). GCR-α expression was significantly higher in C + patients compared to NC. Patients with higher cortisol levels were more likely to progress to respiratory function deterioration or die. Both GCR-α and GILZ expression were significantly higher in C + non-survivors.

Conclusion

Our findings indicate that cortisol serves as an indicator of disease severity. GILZ expression appears to be a more effective marker of mortality prediction in moderate COVID-19 cases. However, routine measurement of GILZ levels is currently unavailable. Elevated levels of cortisol may be indicative of patients with moderate COVID-19 who are at a higher risk of deterioration. This information can aid in identifying individuals who require early medical attention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

Data are available upon reasonable request.

References

  1. Wong CKH, Wong JYH, Tang EHM, Au CH, Wai AKC (2020) Clinical presentations, laboratory and radiological findings, and treatments for 11,028 COVID-19 patients: a systematic review and meta-analysis. Sci Rep 10:19765

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ramasamy S, Subbian S (2021) Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis. Clinical microbiology reviews 34.

  3. Thakur M, Datusalia AK, Kumar A (2022) Use of steroids in COVID-19 patients: a meta-analysis. Eur J Pharmacol 914:174579

    Article  CAS  PubMed  Google Scholar 

  4. Boonen E, Bornstein SR, Van den Berghe G (2015) New insights into the controversy of adrenal function during critical illness. Lancet Diabetes Endocrinol 3:805–815

    Article  CAS  PubMed  Google Scholar 

  5. Kanczkowski W, Evert K, Stadtmüller M, Haberecker M, Laks L, Chen LS, Frontzek K, Pablik J, Hantel C, Beuschlein F, Kurth T, Gruber S, Aguzzi A, Varga Z, Bornstein SR (2022) COVID-19 targets human adrenal glands. Lancet Diabetes Endocrinol 10:13–16

    Article  CAS  PubMed  Google Scholar 

  6. Quatrini L, Ugolini S (2021) New insights into the cell- and tissue-specificity of glucocorticoid actions. Cell Mol Immunol 18:269–278

    Article  CAS  PubMed  Google Scholar 

  7. Vassiliou AG, Athanasiou N, Keskinidou C, Jahaj E, Tsipilis S, Zacharis A, Botoula E, Diamantopoulos A, Ilias I, Vassiliadi DA, Tsagarakis S, Kotanidou A, Dimopoulou I (2019) Increased Glucocorticoid Receptor Alpha Expression and Signaling in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Med 49(2021):2131–2136

    Google Scholar 

  8. Kanczkowski W, Gaba WH, Krone N, Varga Z, Beuschlein F, Hantel C, Andoniadou C, Bornstein SR (2022) Adrenal gland function and dysfunction during COVID-19. Hormone Metabolic Res 54:532–539

    Article  CAS  Google Scholar 

  9. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, M American College of Critical Care (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36:1937–49

    Article  CAS  PubMed  Google Scholar 

  10. Tan T, Khoo B, Mills EG, Phylactou M, Patel B, Eng PC, Thurston L, Muzi B, Meeran K, Prevost AT, Comninos AN, Abbara A, Dhillo WS (2020) Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol 8:659–660

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Das L, Dutta P, Walia R, Mukherjee S, Suri V, Puri GD, Mahajan V, Malhotra P, Chaudhary S, Gupta R, Jayant SS, Agrawal K, Kumar V, Sachdeva N, Rastogi A, Bhadada SK, Ram S, Bhansali A (2021) Spectrum of endocrine dysfunction and association with disease severity in patients with COVID-19: insights from a cross-sectional, observational study. Front Endocrinol 12:645787

    Article  Google Scholar 

  12. Güven M, Gültekin H (2021) Could serum total cortisol level at admission predict mortality due to coronavirus disease 2019 in the intensive care unit? a prospective study. Sao Paulo Med J 139:398–404

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, Herman JP (2008) Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 19:175–180

    Article  CAS  PubMed  Google Scholar 

  14. Alzahrani AS, Mukhtar N, Aljomaiah A, Aljamei H, Bakhsh A, Alsudani N, Elsayed T, Alrashidi N, Fadel R, Alqahtani E, Raef H, Butt MI, Sulaiman O (2021) The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocrine practice 27:83–89

    Article  PubMed  Google Scholar 

Download references

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. A. Vassiliadi.

Ethics declarations

Conflict of interests

The authors have no competing interests to declare that are relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Athanasiou, N., Diamantopoulos, A., Keskinidou, C. et al. Adrenal function in relation to cytokines and outcome in non-critically ill patients with COVID-19. J Endocrinol Invest 47, 721–728 (2024). https://doi.org/10.1007/s40618-023-02189-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-023-02189-y

Keywords

Navigation